EP Patent

EP2278987A4 — Modulation and repletion/enhancement of the complement system for treatment of trauma

Assigned to Dynatron AG · Expires 2012-08-22 · 14y expired

What this patent protects

Patent listed against zilucoplan-sodium.

Drugs covered by this patent

zilucoplan-sodium (ZILUCOPLAN SODIUM)

Patent Metadata

Patent number: EP2278987A4
Jurisdiction: EP
Classification: —
Expires: 2012-08-22
Drug substance claim: No
Drug product claim: No
Assignee: Dynatron AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.